Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Polymorphism Analysis Reveals Joint Effects in Males With Chronic Central Serous Chorioretinopathy. | Invest Ophthalmol Vis Sci | 2023 | 37067365 | PubTator, text mining | PubMed |
| Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis. | PeerJ | 2023 | 37065697 | PubTator, text mining | PubMed |
| Characteristics and management of thrombotic microangiopathy in kidney transplantation. | Korean J Transplant | 2023 | 37064766 | PubTator, text mining | PubMed |
| Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway. | Transl Lung Cancer Res | 2023 | 37057119 | PubTator, text mining | PubMed |
| The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases. | Eur J Hum Genet | 2023 | 37032353 | PubTator, text mining | PubMed |
| End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report. | Vaccines (Basel) | 2023 | 36992263 | PubTator, text mining | PubMed |
| Role of Adhesion G Protein-Coupled Receptors in Immune Dysfunction and Disorder. | Int J Mol Sci | 2023 | 36982575 | PubTator, text mining | PubMed |
| Molecular insight in intrarenal inflammation affecting four main types of cells in nephrons in IgA nephropathy. | Front Med (Lausanne) | 2023 | 36968836 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals underlying host responses in pediatric respiratory syncytial virus pneumonia. | iScience | 2023 | 36968072 | PubTator, text mining | PubMed |
| Comparison of Plasma Exosome Proteomes Between Obese and Non-Obese Patients with Type 2 Diabetes Mellitus. | Diabetes Metab Syndr Obes | 2023 | 36915396 | PubTator, text mining | PubMed |
| Prader-Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review. | Int J Mol Sci | 2023 | 36901699 | PubTator, text mining | PubMed |
| Zinc Supplementation Induced Transcriptional Changes in Primary Human Retinal Pigment Epithelium: A Single-Cell RNA Sequencing Study to Understand Age-Related Macular Degeneration. | Cells | 2023 | 36899910 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy. | Cells | 2023 | 36899849 | PubTator, text mining | PubMed |
| Prognostic and functional roles of EIF4G1 in lung squamous cell carcinoma. | Hum Cell | 2023 | 36897548 | PubTator, text mining | PubMed |
| Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization. | Nat Commun | 2023 | 36894533 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome Activation in Peripheral Arterial Disease. | J Am Heart Assoc | 2023 | 36892058 | PubTator, text mining | PubMed |
| Autoantibodies against complement factor B in rheumatoid arthritis. | Front Immunol | 2023 | 36891314 | PubTator, text mining | PubMed |
| Structural modelling of human complement FHR1 and two of its synthetic derivatives provides insight into their in-vivo functions. | Comput Struct Biotechnol J | 2023 | 36851916 | PubTator, text mining | PubMed |
| Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy. | Blood Cancer J | 2023 | 36849497 | PubTator, text mining | PubMed |
| Genetic stratification reveals COL4A variants and spontaneous remission in Egyptian children with proteinuria in the first 2 years of life. | Acta Paediatr | 2023 | 36847718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=10